Skip to search formSkip to main contentSkip to account menu

batanopride

Known as: 4-amino-5-chloro-N-(2-(diethylamino)ethyl)-2-(1-methyl-2-oxopropoxy)benzamide 
A serotonin antagonist having antiemetic properties.
National Institutes of Health

Related topics

Related topics

4 relations

Narrower (1)

BMY 25801

Broader (1)

Metoclopramide
analogs & derivativesbatanopride hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Double-blind, randomized crossover study of metoclopramide and batanopride for prevention of cisplatin-induced emesis
SummaryWe conducted a double-blind, randomized crossover study to compare the toxicity and antiemetic efficacy of the 5… 
2004
2004
The disposition and protein binding of batanopride and its metabolites in subjects with renal impairment
SummaryWe have studied the disposition of batanopride and its three major metabolites (the erythro-alcohol, threo-alcohol, and N… 
Review
1991
Review
1991
5-HT3 Receptor Antagonists
SummaryThe serotonin (5-hydroxytryptamine, 5-HT) antagonists, which bind at the type 3 receptor (5-HT3 receptor), have been… 
1991
1991
A PHASE II RANDOMISED DOUBLE-BLIND CROSSOVER STUDY COMPARING THE EFFICACY AND SAFETY OF BATANOPRIDE (BMY 25801) TO METOCLOPRAMIDE IN PATIENTS RECEIVIN G CISPLATIN
Review
1990
Review
1990
Batanopride (BMY-25801): a new 5-HT3 receptor antagonist for the prevention of cancer chemotherapy-induced emesis.
1990
1990
Batanopride(BMY-258Ol):anew5-HT,receptor antagonistforthepreventionofcancer chemotherapy-inducedemesis
Nausea and vomiting is a common side-effect of cancer chemotherapy. Its impact on the quality of life may be of major… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)